# SGLT2 Inhibitors: A Broad Impact Therapeutic Option for the Nephrologist

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/sglt2-inhibitors-a-broad-impact-therapeutic-option-for-the-nephrologist/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Antonio Granata,Francesco Pesce,Massimo Iacoviello,Massimiliano Anzaldi,Francesco Amico,Maria Rosaria Catalano,Giuseppe Leonardi,Carmela Gatta,Giusy Costanza,Salvatore Corrao,Loreto Gesualdo |
| Citations | 10 |
| DOI | 10.3389/fneph.2022.867075 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.frontiersin.org/articles/10.3389/fneph.2022.867075/pdf |
| OpenAlex ID | https://openalex.org/W4225116084 |
| PMID | 37674992 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Antonio Granata](https://scholariq.org/researchers/antonio-granata/)
- [Salvatore Corrao](https://scholariq.org/researchers/salvatore-corrao/)
- [Massimo Iacoviello](https://scholariq.org/researchers/massimo-iacoviello/)
- [Francesco Pesce](https://scholariq.org/researchers/francesco-pesce/)
- [Loreto Gesualdo](https://scholariq.org/researchers/loreto-gesualdo/)

## Paper funders

- [AstraZeneca](https://scholariq.org/funders/astrazeneca/)

## Paper journal

- [Frontiers in Nephrology](https://scholariq.org/journals/frontiers-in-nephrology/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Apelin-related biomedical research](https://scholariq.org/topics/apelin-related-biomedical-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.